NasdaqGS - Nasdaq Real Time Price USD
IGM Biosciences, Inc. (IGMS)
1.1500
-0.0400
(-3.36%)
At close: May 13 at 4:00:02 PM EDT
1.1595
+0.01
+(0.83%)
After hours: May 13 at 6:20:52 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Mary Beth Harler M.D. | CEO & Director | 754.54k | -- | 1965 |
| Mr. Misbah Tahir CPA | Chief Financial Officer | 678.27k | -- | 1975 |
| Dr. Lisa L. Decker Ph.D. | Chief Business Officer | 555.09k | -- | 1969 |
| Mr. TS Harigopal | Senior Vice President of Group Operations | -- | -- | -- |
| Mr. Steven Weber | Senior VP, Corporate Controller & Principal Accounting Officer | -- | -- | 1977 |
| Mr. Paul C. Graffagnino J.D. | Senior Vice President of Legal Affairs | -- | -- | -- |
| Ms. Suzette Tauber | Chief Human Resources Officer | -- | -- | 1964 |
| Ms. Elaine Sapinoso | Senior Vice President of Quality | -- | -- | -- |
IGM Biosciences, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 149
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.
Corporate Governance
IGM Biosciences, Inc.’s ISS Governance QualityScore as of May 1, 2025 is 10. The pillar scores are Audit: 5; Board: 9; Shareholder Rights: 10; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 12, 2025 at 12:30 PM UTC - August 18, 2025 at 12:30 PM UTC
IGM Biosciences, Inc. Earnings Date
Recent Events
Related Tickers
APGE Apogee Therapeutics, Inc.
39.74
+0.40%
ARTV Artiva Biotherapeutics, Inc.
2.0500
-2.38%
XNCR Xencor, Inc.
8.11
-7.53%
KROS Keros Therapeutics, Inc.
13.47
-1.97%
ALXO ALX Oncology Holdings Inc.
0.4810
+10.52%
HLVX HilleVax, Inc.
1.9200
+1.59%
RLYB Rallybio Corporation
0.2980
-3.87%
PLRX Pliant Therapeutics, Inc.
1.3800
-6.12%
PMVP PMV Pharmaceuticals, Inc.
0.8522
-1.37%
PRTC PureTech Health plc
17.00
+2.72%